US FDA to curtail use of primate testing in drug trials, FT reports

The U.S. Food and Drug Administration said it would stop requiring pharmaceutical companies to use lab monkeys for some safety studies, the Financial Times reported on Tuesday,

Toxicity testing on primates that can last up to six months can now be reduced or eliminated, the paper said.

Reuters could not immediately verify the report.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)